Answers are grounded in this paper and cite their sources.
This revised article addresses Q0150, 'What molecular features determine whether a polymer will undergo useful bond-selective cleavage rather than random degradation?' using a question-specific mathematical construction rather than a generic logarithmic template. The proposed model, termed the Molecular-Feature Bond-Selective Cleavage Model, uses bond features x_b, activation barrier DeltaG‡_b, cleavage probability p_b, local strain/polarity and product utility and is ordered along bond identity along polymer sequence and reaction condition. The construction is anchored to external primary research classified as DIRECT SUPPORT in the validation atlas. The external evidence establishes experimentally measurable mechanisms or target performance; it is not conflated with proof of the new equation itself. The model defines explicit state variables, derives a dimensionless objective or hazard, specifies a prospective calibration procedure, and states falsifiable predictions. The experimental constraint carried forward from the atlas is: Mechanophore placement, heteroatom insertion and catalyst/mass-transfer studies show molecular features can direct selective cleavage. The article incorporates the required correction: Use bond-class-specific activation descriptors.
No takes yet. Share an insight, caveat, or question.
begüm yıldırım (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: